Optiscan Imaging Faces Revenue Decline, Focuses on Growth
Company Announcements

Optiscan Imaging Faces Revenue Decline, Focuses on Growth

Optiscan Imaging Limited (AU:OIL) has released an update.

Optiscan Imaging Limited reported a significant 31.2% drop in revenues and a 39.3% increase in losses for the financial year ending June 30, 2024, primarily due to decreased orders from key customer Carl Zeiss Meditec. Despite the decline in sales, the company raised $16.7 million through a capital offer to fund strategic expansion and reported an increase in net assets. They continue to invest heavily in R&D, leading to the unveiling of a new medical imaging device, InVue™, and expanding their US operations.

For further insights into AU:OIL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskOptiscan and Monash University Partner for AI-Powered GI Endoscope
TipRanks Australian Auto-Generated NewsdeskOptiscan Imaging Reports Strong Growth and Strategic Advances
TipRanks Australian Auto-Generated NewsdeskOptiscan Imaging Expands US Market Presence Through Key Events
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App